目的:概述法国子宫内膜瘤的治疗方法。
方法:我们在2021年10月至2022年1月期间对子宫内膜瘤的管理方法进行了全国性的调查。这项研究是通过向用于治疗子宫内膜异位症的手术中心(n=62)和辅助生殖技术(ART)中心(n=102)发送的两份问卷进行的。
结果:在调查结束时,来自所联系中心的39/62(62.9%)手术团队给予了响应,51/102(50.0%)MAP中心给予了响应。腹腔镜膀胱切除术是近三分之二的手术团队(61%)在没有已知的不孕症时最常用的技术。而这是仅14%的ART团队最常见的技术。相反,在超过一半的ART团队(56%)中,超声引导下的硬化疗法是最常见的技术,在手术团队中,仅有8%的患者是最常见的技术.如果复发,49%的手术团队会选择超声引导下的硬化治疗。在IVF之前,73%的MPA团队表示,他们“很少”治疗子宫内膜瘤。
结论:我们的研究结果表明,在法国,子宫内膜瘤的治疗在不同中心之间的实践中存在一定的差异,这取决于是否存在不孕症。
To present an overview of French practices for the management of endometriomas.
We carried out a nationwide survey of practices concerning the management of endometriomas between October 2021 and January 2022. This study was carried out by means of two questionnaires sent to surgical centers used to treat endometriosis (n=62) and to Assisted Reproductive Technology (ART) centers (n=102).
At the end of the survey, 39/62 (62.9%) surgical teams from the centers contacted had given a response and 51/102 (50.0%) from ART centers. Laparoscopic cystectomy was the technique most frequently used by almost two thirds of the surgical teams (61%) when there was no known infertility, whereas it was the most common technique for only 14% of the ART teams. On the contrary, ultrasound-guided sclerotherapy was the most frequent technique for more than half of the ART teams (56%) and for only 8% of the surgical teams. In case of recurrence, 49% of surgical teams would choose ultrasound-guided sclerotherapy. Prior to IVF, 73% of ARP teams stated that they \'rarely\' treated endometriomas.
The results of our study show a certain variability in practices between different centers and depending on the presence or absence of infertility for the management of endometriomas in France.